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Abstract
Bone marrow stromal cells (BMSC) transplanted into the contused spinal cord may support repair by improving
tissue sparing. We injected allogeneic BMSC into the moderately contused adult rat thoracic spinal cord at
15min (acute) and at 3, 7, and 21 days (delayed) post-injury and quantified tissue sparing and BMSC survival up
to 4 weeks post-transplantation. BMSC survival within the contusion at 7 days post-transplantation was sig-
nificantly higher with an acute injection (32%) and 3-day delayed injection (52%) than with a 7- or 21-day
delayed injection (9% both; p< 0.01). BMSC survival at 28 days post-transplantation was close to 0 in all
paradigms, indicating rejection. In contused rats without a BMSC transplant (controls), the volume of spared
tissue gradually decreased until 46% ( p< 0.001) of the volume of a comparable uninjured spinal cord segment at
49 days post-injury. In rats with BMSC, injected at 15min, 3, or 7 days post-injury, spared tissue volume was
significantly higher in grafted rats than in control rats at the respective endpoints (i.e., 28, 31, and 35 days post-
injury). Acute and 3-day delayed but not 7- and 21-day delayed injection of BMSC significantly improved tissue
sparing, which was strongly correlated (r¼ 0.79–1.0) to BMSC survival in the first week after injection into the
contusion. Our data showed that neuroprotective effects of BMSC transplanted into a moderate rat spinal cord
contusion depend strongly on their survival during the first week post-injection. Acutely injected BMSC elicit
more tissue sparing than delayed injected BMSC.
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Introduction
Acontusion of the adult spinal cord causes acutedeath of neural cells at the lesion epicenter and sets off a
series of events resulting in additional tissue loss and the
formation of cystic cavities (Hagg and Oudega, 2006).
Transplantation of growth-promoting cells is considered a
promising approach for repair of the contused spinal cord
(Oudega and Xu, 2006; Barnett and Riddell, 2007).
Bone marrow stromal cells (BMSC) are among the candi-
dates for cell-based spinal cord repair strategies (Nandoe
Tewarie et al., 2006). These mesenchymal cells secrete growth
factors that could support repair (Garcia et al., 2004; Mah-
mood et al., 2004; Song et al., 2004; Chen et al., 2005). Their
potential was confirmed by the finding that transplantation of
BMSC into the contused adult rat spinal cord resulted in
functional recovery (Hofstetter et al., 2002; Wu et al., 2003;
Ohta et al., 2004; Zurita and Vaquero, 2004, 2006). The
mechanisms underlying these functional improvements ob-
served after BMSC transplantation are incompletely under-
stood.
A BMSC graft could contribute to repair by sparing spinal
cord nervous tissue at the site of transplantation. It is known
that BMSCs secrete brain-derived neurotrophic factor (BDNF)
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(Mahmood et al., 2004), which has been implicated in limiting
spinal cord tissue loss after injury (Ruitenberg et al., 2003). At
present, the evidence for BMSC grafts to elicit tissue sparing in
the injured spinal cord is still ambiguous (Wu et al., 2003;
Ohta et al., 2004; Yoshihara et al., 2006).
Following an insult to the spinal cord, a cytotoxic envi-
ronment develops at the injury epicenter to diminish in
strength over time (Hagg and Oudega, 2006). Most likely
these circumstances decrease the survival of cells transplanted
into the lesion and consequently their effects on spinal cord
repair. At present, quantitative evidence of the survival and
neuroprotective effects of BMSCs transplanted into a spinal
cord contusion is sparse, which obscures their spinal cord
repair potential. We transplanted BMSCs into a moderately
contused adult rat spinal cord at 15min (acutely) and at
3, 7, and 21 days (delayed) post-injury and determined
tissue sparing and BMSC survival up to 4 weeks post-
transplantation.
Methods
Timeline of the experiment
Rats received a moderate contusion of the T9 spinal cord.
Some of these rats received a BMSC injection into the injury
epicenter at 15min, 3, 7, or 21 days post-contusion. These
BMSC-transplanted rats were euthanized at 15min, 3, 7, and
28 days post-injection. Other contused rats did not receive the
BMSC injection (control rats) and, to match survival times of
the BMSC-transplanted rats, were euthanized at 15min, and
3, 7, 10, 14, 21, 24, 28, 31, 35, and 49 days post-injury. Their
spinal cords were removed and prepared for histology to
enable analysis of tissue sparing and BMSC numbers. Details
on the used techniques are described below.
Animals
Adult female Sprague-Dawley rats (n¼ 121, 160–180 g;
Harlan, Indianapolis, IN) were used in these experiments. All
animals were housed according to the guidelines of the Na-
tional Institutes of Health and the United States Department
of Agriculture. The institutional Animal Care and Use Com-
mittees of the University of Miami and Johns Hopkins Uni-
versity approved all surgical procedures.
Culture and lentiviral transduction of BMSCs
BMSCs were obtained from the marrow of femurs and
tibias of adult female Sprague-Dawley rats (n¼ 8), according
to a previously published protocol (Azizi et al., 1998). Passage
0 cells were infected with lentiviral vectors (LV) encoding for
green fluorescent protein (GFP) at an MOI of 150. The vectors
were generated using the ViraPower Lentiviral Expres-
sion System (Invitrogen, Carlsbad, CA) (Blits et al., 2005).
Expression was under control of the human cytomegalo-
virus promoter and the Woodstuck hepatitis virus post-
transcriptional regulatory element (Naldini et al., 1996). The
titer of the lentiviral stocks varied from 1–3109 TU=mL.Only
passage 3 cultures with a transduction rate of about 95%were
used for transplantation.
With enzyme-linked immune sorbent assays (ELISA) we
determined whether the BMSC secreted BDNF and glial cell-
derived neurotrophic factor (GDNF). For this, medium of
nearly confluent passage 3 cultures (with an average of 2106
cells) was refreshed, removed 24 h later, and used for BDNF
ELISA (BDNF Emax ImmunoAssay System, Promega, Ma-
dison, WI) and GDNF ELISA (GDNF Emax ImmunoAssay
System, Promega) according to the manufacturer’s instruc-
tions. Standard curves of the ELISA kits were linear between
7.8 and 500pg=mL for BDNF and 15.6 and 1000 pg=mL for
GDNF. ELISAs were analyzed with a microplate reader
(SpectraMax M5, Molecular Devices, Sunnyvale, CA). The
cells in culture secreted 14.1 pg=mL=24 h of BDNF. The
amount of GDNFwas below the reliability level of the ELISA.
Contusion injury
The rats (n¼ 108) were anesthetized with 1–2% isoflurane
in oxygen and their backs were shaved and cleaned with
Betadine and 70% alcohol. Lacrilube ophthalmic ointment
(Allergen Pharmaceuticals, Irvine, CA) was applied to the
eyes and gentamicin (1.2mg in 0.03mL; Abbott Laboratories,
North Chicago, IL) was injected intramuscularly. During
surgery, rats were kept on a heating pad to maintain their
body temperature at 37 0.58C. A laminectomy was per-
formed at the eighth thoracic vertebra to expose the ninth
thoracic spinal cord segment, which was subsequently mod-
erately contused (10 g, 12.5mm NYU impactor) (Gruner,
1992). To ensure consistency among contused rats, the con-
tusion impact velocity and compression were monitored and
all rats with >5% error in these measurements were removed
from the study. Rats that remained in the study displayed
hindlimb paralysis and scored <3 at 1 day and <7 at 3 days
post-injury on the Basso-Beattie-Bresnahan (BBB) scale (Basso
et al., 1995). Implementation of these criteria ensured appro-
priateness of the contusion injury and consistency among the
experimental animals. All laminectomies and injuries were
performed by the same investigator. After injury, overlying
muscles were sutured in layers and the skin was closed with
metal wound clips. The rats received 10mL Ringer’s solution
subcutaneously and 1.2mg gentamicin intramuscularly. The
rats were kept in a small animal incubator at 378C until full
recovery and then returned to their cages with ad libitum ac-
cess to water and food. During the first week post-injury,
1.2mg gentamicin was administered intramuscularly on a
daily basis. The analgesic buprenorphine (0.006mg; Bupre-
nex, Reckitt Benckiser, Richmond, VA) was administered
subcutaneously immediately after surgery and once for the
next 3 days. The bladders were expressed manually twice a
day until reflex bladder function returned. Urinary tract in-
fection did not occur in any of the rats.
BMSC transplantation
Contused rats were anesthetized with an intramuscular
injection of 25.7mg=kg ketamine, 5.14mg=kg xylazine, and
0.85mg=kg acepromazine, and their contused spinal cordwas
exposed. A total of 1106 BMSC in 5 mL DMEM was injected
into the contusion epicenter using techniques described pre-
viously (Hurtado et al., 2006). BMSC injections were made at
15min, 3, 7, and 21 days post-contusion. In the 15min group,
the rats remained sedated with the contused spinal cord
covered with a saline-moistened gauze until BMSC injection.
All transplantations were performed by the same investiga-
tor. After injection, muscles were sutured in layers and the
skin closed with metal wound clips. Post-surgery care was as
described above.
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Assessment of BMSC viability
during the injection procedures
The effects of the injection procedures on the number of
BMSCs were determined in vitro using the same tools and
methods as those used for actual transplantation. First, we
assessed the viability of 1106 BMSC in 5 mL DMEM in an
Eppendorf tube after 5 h on ice (the typical length of a trans-
plantation session). A sample of these cells was stained with
Trypan Blue (1:1; Sigma, St. Louis, MO) and the percentage of
living (unstained) BMSCs was calculated using a hemocy-
tometer. Second, we assessed BMSC viability after injection.
BMSCs in DMEM were kept on ice for 5 h and then injected
into an Eppendorf tube (1106 BMSC in 5 mLDMEMper tube)
using the same pulled glass injection needle attached to a
Hamilton syringe as used for transplantation into the rat
spinal cord. These cells were then kept at 378C=5% CO2 for 1,
3, and 5h (n¼ 3 for each time point). BMSCs that were not
passed through the glass needle and kept in the incubator for
the same time periods served as controls (n¼ 3 for each time
point). At the selected times, and immediately after passing
through the glass needle (time point 0), cells were stainedwith
Trypan Blue (1:1) and the percentage of living (unstained)
BMSCs was calculated using a hemocytometer. The effect of
passing through the glass needle was determined by the dif-
ference in the percentages of living BMSC between control
and time point 0 cells. Whether the incubation conditions had
affectedBMSCdeath in timewascalculated fromthedifference
in viability between control cells and cells that were passed
through the glass needle at 1, 3, and 5 h. Third, we determined
howmany cells passed through the needle. A sample of 1106
BMSC in 5mL DMEM that was injected into an Eppendorf
tube using a pulled glass needle attached to a Hamilton sy-
ringe was stained with trypan blue to calculate the total
number of living (unstained) BMSCs using a hemocytometer.
Histological procedures
At 15min, 3, 7, and 28 days after BMSC injection, rats were
anesthetized as above (note that the 15-min group remained
anesthetized until fixation). Control rats that were contused
but did not receive a BMSC transplant were anesthetized
15min, and 3, 7, 10, 14, 21, 24, 28, 31, 35, and 49 days post-
injury. These time points correspond with the survival times
of the BMSC-transplanted rats. After deep sedation was
confirmed, the heart was exposed and 0.1mL Heparine
(500 IU; Henry Schein, Melville, NY) injected into the left
ventricle. Next, 500mL saline followed by 500mL ice-cold 4%
paraformaldehyde in phosphate buffer (PB; 0.1M, pH 7.4)
was pumped through the vascular system. The spinal cord
was removed and kept overnight in the same fixative at 48C.
Then a 15mm long segment of the spinal cord centered at the
contusion was dissected out, kept in phosphate-buffered 30%
sucrose (0.1M, pH 7.4) for 48 h, and frozen within Shandon
M-1 Embedding Matrix (Thermo Electron Corporation,
Pittsburgh, PA). From these blocks, 20 mm thick horizontal
sectionswere cut on a cryostat, mounted onto glass slides, and
stored at 208C.
From some rats of each group, a 1mm thick section was
taken from the epicenter of the lesion for preparation of semi-
thinplastic sections for light microscopy. The 1mm thick tis-
sue blocks were kept in 2% glutaraldehydewith 3% sucrose in
PB for at least 24 h at 48C, in 1% osmium tetraoxide in PB for
12–16 h, dehydrated, and embedded in Epon-Araldite (Elec-
tron Microscopy Services, Fort Washington, PA). One mm
thick transverse sections were cut on a Reichert-Jung ultra-
microtome, stained with a 1% toluidine blue-1% methylene
blue-1% sodium borate solution, and used to analyze general
histology of the spinal cord and transplant and determine
tissue loss at the injury=transplant epicenter.
Measurement of spinal cord tissue sparing
Sparing of spinal cord tissue was assessed in a blinded
fashion in horizontal cresyl violet-stained cryostat sections
using the Cavalieri estimator function of Stereo Investigator
(MBF Bioscience, Williston, VT). All measurements were
taken by the same investigator. From each animal, every tenth
cryostat section (200 mm intervals) was used to determine the
volume of a 5mm long segment centered at the contusion=
transplantation epicenter and that of spared tissue within this
segment. Tissue was considered spared if it lacked cavities,
areas with high density of infiltrating small cells, resembling
neutrophilsandlymphocytes,andneuronswithdarklystained
cytoplasmic Nissl bodies (Takami et al., 2002). The volume of
spared tissue was expressed as a percentage of the average
volume of a comparable uninjured spinal cord segment.
Measurement of BMSC number
within the contused spinal cord
From each rat transplanted with BMSCs, every tenth cryo-
stat sectionwas coveredwith a glass slipwith Vectashieldwith
DAPI (4’-6-diamidino-2-phenylindole, Vector Laboratories,
Burlingame, CA) and used to determine the number of GFP-
positive BMSCs in the contusion. In these sections, in a blinded
fashion, the contusion area with GFP-positive cells was out-
lined under a 2.5x objective. Then, under a 63x objective (oil
immersion), grids of 250 by 250mm (counting frame area,
625mm2) were placed over the outlined area and each GFP-
positive cell with a recognizable nucleuswas counted using the
optical fractionator function of Stereo Investigator (MBF
Bioscience, Williston, VT). The sampling interval was:
x¼ 250mm, y¼ 250mm. All measurements were taken by the
same investigator. The resulting numbers were used to calcu-
late the total number of GFP-positive BMSC within the con-
tusion. These total numbers were then expressed as a
percentage of the total number found at 15min post-injection.
Assessment of BMSC migration
We found that transplanted BMSC had migrated away
from the injection site. Their number, location, and distance
from the contusion epicenter were determined in one series of
cryostat sections of each of the transplanted rats. Because it is
possible that BMSC had migrated beyond 8mm, which was
the approximate distance from the injury epicenter to the edge
of the section in rostral and caudal direction, we also sectioned
and examined the contiguous 10mm long rostral and caudal
spinal cord segment. All GFP-positive BMSC outside of the
contusion were counted manually under a 40x objective.
Statistical analysis
We used Sigmastat (Systat Software, San Jose, CA) for the
statistical analyses. The t test was used to determine differ-
ences between groups, which were accepted at p< 0.05. The
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relationship between tissue sparing and BMSC number was
determined by the Pearson correlation coefficient (r).
Results
BMSC transplants in the contused spinal cord
With all transplantation paradigms, GFP-positive BMSCs
were found within the contusion at 15min after the injection
(Fig. 1A–C). The number of BMSCs within the contusion was
noticeably decreased at 7 days (Fig. 1D–F) and 28 days (Fig.
1G–I) after injection.
Spared tissue in the contused adult rat spinal cord
Wequalitatively assessed the contused spinal cord segment
of adult rats without (controls) and with a BMSC transplant
using toluidine blue-stained transverse semi-thin plastic sec-
tions of the contusion epicenter and cresyl violet-stained
horizontal cryostat sections of the contused spinal cord seg-
ment (Fig. 2). In transverse plastic sections, a loosely orga-
nized transplant that filled up the contusion was found at 3
days after an acute injection (Fig. 2A). At 28 days after a BMSC
injection into the 21-day-old contusion, the spinal cord was
not only decreased in size but also contained one or more
FIG. 2. Spared tissue in the contused adult rat spinal cord after BMSC transplantation. (A) Loosely organized tissue in
contusion epicenter at 3 days after an acute BMSC injection. (B) Cavities present in the contusion epicenter at 28 days after a
21-day delayed transplantation of BMSCs. Note that the spinal cord has also decreased in size. (C) At 3 days after acute BMSC
injection, damaged tissue but not cavities was observed. (D) At 28 days after acute injection, large cavities were found in the
contused segment. (E) With a 7-day delayed BMSC injection, damaged tissue and a few small cavities were found at 3 days
post-transplantation. (F) At 28 days after BMSC injection into the 7-day-old contusion, large cavities were found in the contused
segment. Images are from toluidine blue-stained transverse semithin plastic sections (A and B). Images are from cresyl violet-
stained horizontal cryostat sections (rostral to the left) (C–F). (A) Scale bar, 150 mm in A and B; (C) scale bar, 600 mm in C–F.
FIG. 1. BMSC transplants within a moderate contusion in the adult rat thoracic spinal cord decrease in size during 28 days
post-injection. The transplant is shown at 15min (A–C), 7 days (D–F), and 28 days (G–I) after an injection at 15min (acute),
7 days, and 21 days, respectively, post-injury. All microphotographs are from horizontal cryostat sections. (A) Scale bar,
600 mm in A–I.
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large cavities (Fig. 2B). On horizontal sections, after an acute
injection, cavities were not present at 3 days (Fig. 2C) but
could be found at 28 days (Fig. 2D). With a 7-day delayed
injection, small cavities were found at 3 days (Fig. 2E) and
much larger ones at 28 days (Fig. 2F) post-injection.
Using Stereo Investigator software, we determined that the
volume of spared tissue in the contused spinal cord segment
gradually decreased to 10.1 1.7mm3 at 49 days post-injury
in control rats and to 11.5 0.9mm3 at 49 days post-injury in
BMSC-transplanted rats (Table 1). Because narrowing of the
contused segment occurs, we determined the volume of
spared tissue relative to that of a comparable segment from
uninjured and untreated spinal cord (21.9 3.4mm3; SD,
n¼ 5; Fig. 3A). We found that with BMSCs injected at 15min,
3 days, or 7 days after injury the volume of spared tissue was
significantly higher in transplanted rats than in control rats at
the respective endpoints (i.e., 28, 31, and 35 days post-injury).
We then determined the relative change in spared tissue
volume in transplanted and control rats between the same
time periods after contusion (Fig. 3B). Importantly, in BMSC-
transplanted rats the volume of spared tissue at 15min after
injection was similar to that found in control rats of matching
survival times. The results show that tissue sparing during the
28 days that BMSCs were present was increased with acute
and 3-day delayed but not 7- and 21-day delayed BMSC
transplantation compared to the loss that occurs in control
rats within the same time periods.
Loss of BMSCs transplanted into the moderately
contused rat spinal cord
We found that 95% of BMSCs survived a period of 5 h on ice
and 92% survivedwhen passed through a pulled glass needle.
Thus, our methods could have resulted in a maximum of 13%
death among BMSCs injected into the contusion. From the
intended 1 million cells, 6.7105 BMSC passed through the
needle alive. Taking the greatest possible percentage of deaths
due to transplantation into account, this implies that 8105
BMSCswere injected into the contusion of which 1.3105 cells
(13%) were dead. To correct for variability due to our proce-
dures, BMSC numbers were expressed as a percentage of the
number found at 15min post-injection.
At 15min post-injection, we found that 35%, 25%, 58%, and
32% of the calculated average of 6.7105 (live) BMSCs were
present and alive in the contusion with the injection made at
15min, 3, 7, and 21 days post-injury, respectively. There was
no direct relationship between the percentages and the timing
of the injection; cell loss during the first 15min post-injection
was 35% with acute and 38% with delayed paradigms.
The average BMSC numbers and corresponding percent-
ages (relative to the number at 15min post-injection) are listed
in Table 2 and Figure 4A and reveal that the number of BMSC
at 7 days post-injection was significantly higher after acute
( p< 0.01) and 3-day delayed ( p< 0.005) injections compared
to 7- and 21-day delayed injections: 32% and 52% vs. 9% and
9%, respectively (Fig. 4B). The number of BMSCs in the con-
tusion at 28 days post-injection was close to 0 in all groups,
indicating rejection of the transplanted cells.
Tissue sparing and BMSC survival
are strongly associated
The relationship between tissue sparing and BMSC sur-
vival was assessed using the Pearson correlation coefficient.
We found that with an acute and 3-days delayed injection, the
positive correlation was large with r¼ 1.0 at 3, 7, and 28 days
post-injection. With a 7-day delayed injection, the positive
correlationwas largewith r¼ 0.79 at 3 days andwith r¼ 1.0 at
7 and 28 days post-injection. With a 21-day delayed injection,
there was no correlation between BMSC number and spared
Table 1. Comparison of Volumes of Spared (Intact) Tissue in Contused Spinal Cord Segments in Rats
With and Without BMSC Transplant
Time of Tr Time after Tr BMSC transplant Controls (no BMSC) Time after con % of control
15min 15min 20.6 3.6 22.3 1.9 15mo 7.6
3 d 19.3 1.4 18.7 1.1 3 d 3.2
7 d 16.6 1.8 13.2 0.8 7 d 25.8**
28 d 15.7 0.8 11 1.6 28 d 42.7***
3 d 15min 18.4 1.2 18.7 1.1 3 d 1.6
3 d 16.8 0.9 13.2 1.4 7 d 27.3**
7 d 16.2 1.4 13.9 1.2 10 d 16.5*
28 d 15.8 1.8 11.8 2.2 31 d 33.9**
7 d 15min 14.1 1.2 13.2 0.8 7 d 6.8
3 d 14.4 0.9 13.9 1.2 10 d 3.6
7 d 13.2 0.6 12.2 1.2 14 d 8.2
28 d 12.7 1.1 11.8 1.7 35 d 7.6
21 d 15min 13.2 1.2 12.2 1.7 21 d 8.2
3 d 13.1 1.4 11.9 1.3 24 d 10.1
7 d 12.8 0.8 11 1.6 28 d 16.4
28 d 11.5 0.9 10.1 1.7 49 d 13.9
Rats were contused and received a BMSC transplant (Tr) at 15min, 3, 7, or 21 days post-injury (column 1). The transplanted rats were
euthanized at 15min, 3, 7, or 28 days after BMSC injection (column 2). The spinal cords were removed and histologically prepared to
determine the volumes of spared (intact) tissue (column 3, SD). These were then compared to those in control rats, which were similarly
contused but did not receive BMSCs (column 4, SD). Survival times of control rats after contusion (con; column 5) were matched with the
total survival times (i.e., pre-injection time plus post-injection time) of BMSC-injected rats. The difference (as percentage of the volume in
controls) was calculated and tested for significance (column 6). A positive value indicates more spared (intact) tissue in the BMSC-
transplanted spinal cord. No asterisks, not significant; *p< 0.05; **p< 0.03; ***p< 0.01.
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tissue volume. Thus, in groups that received the BMSC
transplant during the first week post-contusion, we found a
strong positive association between tissue sparing and BMSC
survival with r values between 0.79 and 1.0.
BMSC migration into adjacent spinal nervous tissue
The number of BMSCs in the transplant site could decrease
as BMSC migrate away from the injection site. We found that
a few days after injection BMSCs started to migrate away
mainly from the rostral and caudal aspects of the transplant
(Fig. 5A). One week after injection, BMSCs were found in the
dorsal and ventral columns, some as far as 7mm away from
the contusion epicenter. Most of these cells were spindle-
shaped with a small nucleus and several extensions (Fig. 5B).
With a 3-day post-injury injection, a total of 2100 849
BMSCs at 7 days and 820 99 at 28 days post-transplantation
had migrated away from the transplant site (Fig. 5C). Sig-
nificantly more BMSCs ( p< 0.001) were found rostral
(80 14%) than caudal (20 9%) to the transplantation site.
The total number of migrated BMSCs represented 1.2% of the
number of BMSCs in the contusion at 15min post-injection
and 2.4% of the number at 7 days post-injection. At 28 days
post-injection, almost twice as many BMSCs were found
outside of the contusion compared to within. Thus, BMSCs
that had migrated away from the injection site into the adja-
cent spinal cord tissue appeared to be protected compared to
those that remained within the contusion.
Discussion
Survival of BMSCs transplanted acutely (15min post-
injury) or delayed (3, 7, and 21 days post-injury) into a
moderately contused adult rat spinal cord is low with few or
none of the cells left at 28 days post-injection. BMSC loss at the
7-day post-injection time point was 68% with acute and 48%
with 3-day delayed injections, which was significantly lower
than with 7- and 21-day (91% both) delayed injections. This
indicates that the contusion environment is more deleterious
to transplanted BMSCs during the second and fourth weeks
after impact than during the first week after impact. In control
rats, the amount of spared tissue gradually decreased in time
until 46% of that in a comparable uninjured spinal cord seg-
ment at 49 days post-injury. The presence of BMSCs resulted
in increased amounts of spared tissue compared to controls.
Acute and 3-day delayed, but not 7- and 21-day delayed, in-
jection of BMSCs significantly improved tissue sparing. There
was a large positive correlation between spared tissue volume
and BMSC number with injections during the first week post-
contusion.
Effects of BMSCs on tissue sparing were assessed by de-
termining the volume of spared (intact) tissue (see above for
criteria; also see Takami et al., 2002) within the contused
spinal cord segment. This revealed an increased volume of
spared tissue at 7 and 28 days post-injury with an acute BMSC
injection and at 6, 10, and 31 days post-injury with a 3-day
delayed BMSC injection. This particular approach of mea-
suring spared tissue is employed regularly but it does not take
into account narrowing of the spinal cord, which typically
occurs after a contusion. Therefore, we also determine the
volume of spared tissue relative to that of a comparable seg-
ment from uninjured and untreated spinal cord (Takami et al.,
2002). This revealed an increased volume of spared tissue at
the above-mentioned time points but also at 35 days post-
injury with a 7-day delayed BMSC injection.
Our results demonstrated that acutely transplanted BMSCs
contributed to sparing of nervous tissue following amoderate
contusion of the thoracic rat spinal cord better than delayed
transplanted BMSCs did. The reduced loss of the acutely
transplanted BMSCs during the first week after injection
correlated closely with the increased volumes of tissue spar-
ing. Previously, it was reported that acutely transplanted
BMSCs reduced the size of cavities at 3 weeks after an injec-
tion into the contusion (Wu et al., 2003) and at 5weeks after an
injection into the fourth ventricle (Ohta et al., 2004). In the
present study, we have assessed spared tissue volume relative
FIG. 3. BMSC transplantation elicits tissue sparing in the
contused adult rat spinal cord. (A) Bar graph showing the
volumes of spared tissue in the contused spinal cord segment
in rats without (control, open bars) and with (closed bars)
BMSC transplants. Spared tissue volume is expressed as a
percentage of the volume of a comparable uninjured spinal
cord segment. Time points of the x-axis refer to control rats.
The survival times of BMSC-transplanted rats that matched
these time points were 15m=15m, 15m=3d, 15m=7 d,
3 d=7 d, 7 d=7d, 21 d=15m, 21 d=3 d, 15m=28d, 3 d=28 d,
7 d=28 d, and 21 d=28d (see also Table 1). Asterisks indicate a
significant difference control and BMSC transplanted rats
(*p< 0.05; **p< 0.03; ***p< 0.01). (B) Decrease in spared tis-
sue volume occurring during the 28-day time period. The
volume at the endpoint is expressed as a percentage of the
volume at the starting point. The time periods refer to control
rats. The matching time points of transplanted rats are listed
above.
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to that of a comparable segment from an uninjured and un-
treated spinal cord to account for the normally occurring
shrinkage. Despite this difference in approach, our results are
in agreement as they indicated that acutely transplanted
BMSC exert neuroprotective actions on the nervous tissue
within the contused segment. The effects of these neuropro-
tective actions remain visible until 28 days post-transplanta-
tion. In 2006, Yoshihara and collaborators demonstrated that
BMSC transplantation into a 9-day-old moderate contusion
did not result in neuroprotection within the contused seg-
ment, which is in concurrence with our findings that delayed
transplanted BMSCs fail to exert neuroprotective actions. One
potential mechanism by which transplanted BMSCs result in
neuroprotection may be by secreting BDNF (Ruitenberg et al.,
2003; Patist et al., 2004). We used ELISA to confirm that the
BMSCs used for transplantation in our study produced and
secreted BDNF. Future studies in which the production of
BDNF by BMSCs or the actions of BDNF are blocked will help
to elucidate the role of BMSC-derived BDNF on neuropro-
tection.
Our data showed that 0.02% of acutely transplanted
BMSCs had survived up to 28 days in a moderate spinal cord
contusion. In a previous study, it was shown that 0.17% of
BMSC acutely injected into and near a moderate-severe con-
tusion (25mm, NYU impactor) in the rat spinal cord had
survived at 5 weeks post-injury=injection (Hofstetter et al.,
2002). When BMSCs were grafted into a 7-day-old contusion,
six times more cells (0.99%) had survived at 5 weeks post-
injury (i.e., 4 weeks post-injection). In our studywe used a less
severe contusion injury but found a lower BMSC survival at
time points that were close (acute injection, 28 days survival
here vs. 35 days survival observed by Hofstetter et al. [2002])
or exactly matching (7-day delayed injection, 28 days survival
here vs. 35 days survival observed by Hofstetter et al. [2002]),
namely, 0.02 vs. 0.17 and 0 vs. 0.99, respectively. A possible
explanation for this discrepancy is that in Hofstetter et al.
(2002) the BMSCs were injected 2mm rostral and caudal as
well as into the contusion lesion. It was not studied whether
the surviving BMSCs were in fact those injected near rather
than in the contusion, as has been described for a similar
paradigm in a 7-day-old mouse spinal cord contusion model
(Lee et al., 2003). Others have reported BMSC survival in
spinal cord lesions but without quantification (Ankeny et al.,
2004; Ohta et al., 2004; Zurita and Vaquero, 2004, 2006; de
Haro et al., 2005; Cizkova et al., 2006).
Hofstetter et al. (2002) injected BMSCs into the contused
spinal cord acutely or 1-week delayed and examined loco-
motor function of the hind limbs during the ensuing weeks.
Both groups were not directly compared and tested for sig-
nificance, but the data from this study indicated that im-
proved BMSC survival was associated with improved
locomotor function (Hofstetter et al., 2002). In general, this
agrees with our data that improved survival of transplanted
BMSCs elicits positive effects on spinal cord repair. Studies
that investigate the correlation between BMSC survival and
motor and sensory function are in progress.
Survival of grafted BMSCs during the first week post-in-
jection was significantly lower when the cells were grafted 7
and 21 days post-injury compared to 15min and 3 days post-
injury. Normally, immune cells invade contused tissue
rapidly to be followed by inflammatory cells including mac-
rophages. The peak in macrophage presence is around 7 days
post-injury, to recede thereafter (Blight, 1992; Popovich et al.,
1997; Jones et al., 2005). We found that BMSCs survived best
when injected immediately or 3 days after injury, which is
when the number of inflammatory cells is still increasing in
Table 2. Number of BMSCs in Contusion at Different Time Points after Injection
Time of Tr Time after Tr No. of BMSC (SD) % of no. at 15mo (SD) P values within P values between
15min 15min 234064 50568 100 n.s.
3 d 137818 13710 59 6 *** &
7d 75123 6206 32 3 *** #
28 d 650 1170 0 1 *** n.s.
3 d 15min 168159 10829 100 n.s.
3 d 117954 19405 70 12 *** &&
7d 87678 13034 52 8 *** ##
28 d 450 495 0 0 *** n.s.
7 d 15min 387372 38015 100 n.s.
3 d 177267 23869 46 4 ***
7 d 36350 3465 9 1 ***
28 d 1325 2650 0 1 *** n.s.
21 d 15min 217619 29273 100 n.s.
3 d 83300 11281 38 5 ***
7 d 19154 4107 9 2 ***
28 d 4300 3387 2 2 *** n.s.
Rats were contused and received BMSC transplants (Tr) at 15min, 3, 7, or 21 days post-injury (column 1). The rats were euthanized at
15min, 3, 7, or 28 days after injection (column 2) and the spinal cord was histologically prepared to determine the number of GFP-positive
BMSC within the contusion using stereology (column 3). These numbers were expressed as a percentage of the number at 15min after
injection for each group (column 4). Within each group (i.e., injection paradigm; column 5), BMSC numbers at 3, 7, and 28 days post-injection
were significantly lower (***p< 0.01) compared to the previous time points (15min, 3, and 7 days), demonstrating the significant gradual
decrease in BMSC number regardless of the injection time. Between groups, at the same time point (column 6), BMSC number at 15min post-
injection was not different (n.s.). BMSC number at 3 days post-injection was significantly higher with acute (&p< 0.05) and 3-day delayed
injections (&&p< 0.03) compared to 21-day delayed injections. BMSC number at 7 days post-injection was significantly higher with acute
(#p< 0.01) and 3-days delayed (##p< 0.005) compared to 7- and 21-day delayed injections. BMSC number at 15min and 28 days post-
injection were not different (n.s.).
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the contusion lesion. Possibly, macrophages are directly in-
volved in transplanted BMSC loss, which would explain the
greater loss at injection times when more macrophages can be
found in the contusion. The relationship between macro-
phages and transplanted BMSCs within the injured spinal
cord is still poorly understood.
We observed that some of the transplanted BMSCs mi-
grated from the contusion into the rostral and caudal white
matter. To our knowledge, this is the first evidence that
BMSCs transplanted into a contusion site in the adult rat
thoracic spinal cord migrate into the adjacent nervous tissue.
Neuhuber and colleagues (2005) described that human
BMSCs grafted in a hemisection in the adult rat cervical spinal
cord migrated into the nearby spinal tissue. Our data sug-
gested that the conditions at and nearby the 3-day-old spinal
cord contusion permitted migration of the injected BMSCs. In
the injured adult central nervous system, chemotactic factors
and cytokines such as macrophage inflammatory protein-1a,
monocyte chemoattractant protein-1, and interleukin-8 have
been implicated in BMSC migration (Wang et al., 2002).
In sum, we have gathered evidence that BMSCs trans-
planted immediately and 3 days after a contusion survive
better within the lesion environment during the first week
after injection compared to BMSC transplanted at 7 and 21
days post-injury. The improved survival is transient but the
BMSC transplant elicited neuroprotective effects that resulted
in improved tissue sparing up to 28 days after injection.
FIG. 4. BMSC survival in a moderate contusion in the adult
rat thoracic spinal cord is low. (A) The number of BMSCs
transplanted acutely (15min post-injury) or delayed (3, 7,
and 21 days post-injury) into a moderate contusion decreases
over 28 days post-injection. The numbers are expressed as a
percentage of the numbers found at 15min post-injection.
(B) BMSC death within the moderate contusion at 7 days
post-injection is significantly lower after acute and 3-day
delayed injections than with 7- and 21-day delayed injec-
tions. Percentages are relative to the number at 15min post-
transplantation. Bars represent standard error of the mean.
*p< 0.01; **p< 0.005.
FIG. 5. BMSC transplanted into the moderately contused
adult rat spinal cord contusion migrate into spinal cord
white matter. (A) GFP-positive BMSC (arrow) ‘‘leaving’’ the
transplant (T) at its rostral edge. (B) Several GFP-positive
BMSC that have migrated approximately 5mm into the
rostral lateral white matter (WM). (C) Bar graph showing the
number of BMSC that migrated out of a transplant at 7 and
28 days post-injection. BMSC were injected at 3 days post-
injury. All microphotograph confocal images are from hori-
zontal 20mm thick cryostat sections. (A) Scale bar, 15mm in A
and B.
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